Skip to main content

Research Repository

Advanced Search

The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer

Wade, Mark A.; Jones, Dominic; Wilson, Laura; Stockley, Jacqueline; Coffey, Kelly; Robson, Craig N.; Gaughan, Luke

Authors

Profile Image

Dr Mark Wade M.Wade@hull.ac.uk
Senior Lecturer in Molecular Genetics

Dominic Jones

Laura Wilson

Jacqueline Stockley

Kelly Coffey

Craig N. Robson

Luke Gaughan



Abstract

Endocrine therapy has successfully been used to treat estrogen receptor (ER)-positive breast cancer, but this invariably fails with cancers becoming refractory to treatment. Emerging evidence has suggested that fluctuations in ER co-regulatory protein expression may facilitate resistance to therapy and be involved in breast cancer progression. To date, a small number of enzymes that control methylation status of histones have been identified as co-regulators of ER signalling. We have identified the histone H3 lysine 9 mono- and di-methyl demethylase enzyme KDM3A as a positive regulator of ER activity. Here, we demonstrate that depletion of KDM3A by RNAi abrogates the recruitment of the ER to cis-regulatory elements within target gene promoters, thereby inhibiting estrogen-induced gene expression changes. Global gene expression analysis of KDM3A-depleted cells identified gene clusters associated with cell growth. Consistent with this, we show that knockdown of KDM3A reduces ER-positive cell proliferation and demonstrate that KDM3A is required for growth in a model of endocrine therapy-resistant disease. Crucially, we show that KDM3A catalytic activity is required for both ER-target gene expression and cell growth, demonstrating that developing compounds which target demethylase enzymatic activity may be efficacious in treating both ER-positive and endocrine therapy-resistant disease.

Citation

Wade, M. A., Jones, D., Wilson, L., Stockley, J., Coffey, K., Robson, C. N., & Gaughan, L. (2015). The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer. Nucleic Acids Research, 43(1), 196-207. https://doi.org/10.1093/nar/gku1298

Journal Article Type Article
Acceptance Date Nov 29, 2014
Online Publication Date Dec 8, 2014
Publication Date Jan 9, 2015
Deposit Date Feb 4, 2019
Publicly Available Date Mar 12, 2021
Journal Nucleic Acids Research
Print ISSN 0305-1048
Electronic ISSN 1362-4962
Publisher Oxford University Press
Peer Reviewed Peer Reviewed
Volume 43
Issue 1
Pages 196-207
DOI https://doi.org/10.1093/nar/gku1298
Public URL https://hull-repository.worktribe.com/output/1271236
Publisher URL https://academic.oup.com/nar/article/43/1/196/1007966

Files

Published article (4.2 Mb)
PDF

Copyright Statement
©2014, Oxford University Press

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.





You might also like



Downloadable Citations